Earnings Call Transcript Summaries

Thermax Limited THERMAX Q1FY27 📝 Transcript · Capital Goods

Filed 06 Aug 2026

INR 300 crore shipment delay impacted Industrial Products profitability; commodity price rise added INR 10 crore cost
Focus on exiting low-margin government projects; aiming for 10%+ EBITDA margin in Industrial Infra
Q2-Q4 expected to show significant profitability improvement over last year
Q1 FY27 was difficult with a major INR 91 crore loss on a government project due to late engineering changes
Bio-CNG and renewable energy businesses faced losses; policy changes expected to boost bio-CNG pipeline from Q3 FY27
Order backlog strong with expected growth in Industrial Infra, Industrial Products, Chemicals, and Green Solutions

Divi's Laboratories Limited DIVISLAB Q1FY27 📝 Transcript · Healthcare

Filed 06 Aug 2026

Ongoing capex projects nearing completion; validation batches progressing
Gross margin approx. 68% in Q1; full-year margin expected near last year's level
Q1 FY27 consolidated total income ₹3,144 Cr (+24% y-y); PAT ₹902 Cr (+65% y-y)
Regulatory approvals key for commercial ramp-up of new projects
Management targets sustained double-digit revenue growth for FY27
Peptide capacity expanding with new 3,000-liter SPPS installations

Exide Industries Ltd EXIDEIND Q1FY27 📝 Transcript · Automobile and Auto Components

Filed 06 Aug 2026

Lithium-ion plant utilization target 25-30% in FY27; capacity 6 GWh Phase 1, potential expansion to 12 GWh
Lead acid battery capex INR500 Cr annually for capacity and tech upgrades; focus on bottlenecks and brownfield expansions
Standalone Q1 FY27 revenue grew 17.6% y-y; EBITDA INR655 Cr +19.5% y-y; margin 12.4%, +20 bps y-y
Export business grew 20%+; government tenders muted but expected to pick up in H2 FY27
Raw materials mostly imported currently; pilot projects with Indian suppliers underway; electrolyte expected to localize first
Price hikes of 4-6% taken in Q1; further hikes under review; cost pressures from currency and input costs

The Karnataka Bank Limited KTKBANK Q1FY27 📝 Transcript · Financial Services

Filed 06 Aug 2026

Q1 FY27 aggregate business at INR1,97,007 Cr, +3% Q-o-Q, +11% Y-o-Y
ROE 12.48%, ROA 1.29% in Q1 FY27; aiming 1.35-1.40% ROA for FY27
Branch expansion planned: 31-32 new branches in FY27
Gross NPA improved to 2.58%, Net NPA 0.87%; credit cost 0.03%
Focus on reducing bulk deposits, increasing retail deposits to optimize cost
Gross advances INR86,610 Cr, +4% Q-o-Q, +17% Y-o-Y; focus on retail, Agri, MSME growth

Clean Science and Technology Limited CLEAN Q1FY27 📝 Transcript · Chemicals

Filed 06 Aug 2026

Supply chain disruptions impacted volumes in Q1; improvements expected in Q2 but raw material price volatility remains
EBITDA margins expected to improve with higher grade HALS sales and operational efficiencies
Q1 FY27 consolidated revenue grew 10% y-y to INR 264 Cr; standalone revenue down 6% y-y but up 5% q-o-q to INR 203 Cr
Strategic collaboration with Swiss partner Geneus Chem for advanced HALS technology; expected INR 300-350 Cr incremental revenue over 3-4 years
Hydroquinone and catechol plant stabilized; commercial supplies ramping from Q2 FY27
Performance Chemical 2 plant expected commercial start in Q3 FY27 (Nov-Dec 2026)

Cohance Lifesciences Limited COHANCE Q1FY27 📞 Audio · Healthcare

Filed 05 Aug 2026

Price increases passed on to customers to mitigate RM inflation; margin recovery expected weighted towards H2 FY27.
FY27 filings: 7 new APIs targeted; 10 product launches planned in formulations segment.
Q2 expected to show sequential revenue improvement; year-on-year growth anticipated from H2 FY27.
Oligonucleotide business (Sepala) targeting integrated offering and full ownership by FY30; 2.5x revenue growth in Q1.
Specialty Chemicals skewed to H2 FY27 due to seasonality; aiming for double-digit growth from FY28.
Q1 consolidated gross margin at 71.5% vs 73% YoY; impacted by product mix, lower pharma contribution, and higher freight/RM costs.

Cartrade Tech Limited CARTRADE Q1FY27 📝 Transcript · Consumer Services

Filed 05 Aug 2026

Q1 margins impacted by wage increments; expect margin expansion in Q2-Q4
Standalone consumer business revenue stable q-q, up 18% y-y; EBITDA margin 33%
Elite Buyer program crossed 100,000 monthly users; monetization to expand with mandatory paid plans for business buyers
AI tools (VAYA AI) deployed for pricing, condition, matchmaking; incremental cost minimal due to in-house data
Q1FY27 consolidated revenue grew 16% y-y; EBITDA up 45% with margin at 31% (vs 25% last year)
OLX revenue grew 29%, EBITDA surged 76%, PAT up 27% despite tax impact

RSWM Limited RSWM Q1FY27 📞 Audio

Filed 05 Aug 2026

PET food-grade granules project (50,000 MT capacity) to start commercial production Q1 FY28, targeting Rs 500 Cr revenue with ~15% EBITDA margin.
Knitting capacity expansion from 650 to 900 tons/month (including 150 tons printing) expected to start benefiting from Q3 FY27.
Fabric segment margins pressured by volatile raw material costs and subdued export demand; yarn segment performed better.
Geopolitical tensions (West Asia conflict) causing supply chain disruptions, freight cost volatility, and export demand softness.
Fabric business margin pressure due to export market softness and cost inflation in fiber, gas, and chemicals.
Q1 FY27 revenue grew 1.7% QoQ to Rs 1161 Cr; EBITDA margin improved to 8% from 7.4% in Q4 FY26.

Dixon Technologies (India) Limited DIXON Q1FY27 📝 Transcript · Consumer Durables

Filed 05 Aug 2026

Mobile & EMS revenue INR14,179 Cr; operating profit INR373 Cr; Q2 smartphone volume growth guidance 20-25% q-o-q
Q1 FY27 revenue INR15,557 Cr; EBITDA INR472 Cr; PAT INR218 Cr excluding fair value gains
Telecom revenue INR2,100 Cr; expected growth to INR6,700-7,000 Cr in FY27; operating margin ~5.1%
JV with Vivo to start contributing from Q3 FY27; new Noida facility operational Q3
PLI 2 scheme effective April 1, 2026; incentives on incremental production and localization expected to boost volumes and margins
IT hardware revenue INR1,350 Cr; new JV with Inventec operational Q4; server manufacturing to start Q3

Nuvama Wealth Management Limited NUVAMA Q1FY27 📝 Transcript · Financial Services

Filed 05 Aug 2026

Q1 FY27 quarterly profit crossed INR300 crores, surpassing FY22 full-year profit
Asset management losses expected INR35-40 crores in FY27; breakeven expected post Q4
Offshore business breakeven in Dubai; Singapore breakeven expected by year-end
Capital markets: fixed income and institutional equities strong; IPO activity expected to pick up
Cost-to-income ratio steady at 55%; employee cost up 17%, opex up 24% y-y
Technology investments include AI chatbots and voice assistants improving RM productivity

Glenmark Pharmaceuticals Limited GLENMARK Q1FY27 📝 Transcript · Healthcare

Filed 05 Aug 2026

Gross margin impacted by geopolitical cost pressures; full-year margin guidance maintained at 21-22%
India business growth guidance 12-15% with volume-led growth and new product launches
Key priorities: US respiratory launches in H2 FY27, oncology launches Aumolertinib, Trastuzumab Rezetecan, envafolimab
Consolidated revenue grew 23.1% Y-o-Y to INR40.2bn in Q1 FY27; base business up 18% excluding deferred income
R&D spend around INR289cr in Q1; guided at 7-8% of sales; IGI pipeline progressing with multiple clinical trials
Litigation provisions mostly done; no significant incremental cash outflows expected

Swiggy Limited SWIGGY Q1FY27 📝 Transcript · Consumer Services

Filed 05 Aug 2026

Swiggy plans growth focus in quick commerce with contribution margin (CM) near zero to -100 bps in FY27
Food delivery growth guided at 18-20% YoY with under-penetrated market opportunity
Take rate improvement driven by brand monetization, advertising, and user fees; sustainable per management
Instamart leadership changes aim to enhance merchandising and differentiated assortment
4-week Net Order Value growth accelerated to 10% from 1%; store expansions planned in existing cities
Platform frequency impacted by user rationalization; retention at highest levels in many quarters

Balkrishna Industries Limited BALKRISIND Q1FY27 📝 Transcript · Automobile and Auto Components

Filed 05 Aug 2026

Price hike of ~5% taken in Q1; raw material cost expected to impact margin by ~2% in Q2
Q1 FY27 OHT segment volume grew 16% y-y to 93,770 MT; standalone revenue rose 24% y-y to INR3,409 Cr
EBITDA margin at 20.61%, impacted by raw material inflation and higher India volume share
Capex of INR1,000 Cr spent in Q1; INR1,500-2,000 Cr more planned for FY27 (total ~INR3,000 Cr)
Management refrains from forward-looking margin or growth guidance
FY27 On-Highway revenue target INR5,000 Cr by 2030; pan-India distributor network expanding

Berger Paints (I) Limited BERGEPAINT Q1FY27 📞 Audio · Consumer Durables

Filed 05 Aug 2026

GST input tax credit on new plant capex delaying margin benefits until FY26.
Industry growth expected around 12-14%, with Berger targeting ~14% growth driven by distribution expansion, construction chemicals, and industrial coatings.
Competitive intensity may cause slight volume/margin pressure but manageable; worst-case growth impact ~4% reduction.
Margins currently at ~17-18%, expected to moderate slightly to 16-17% due to pricing pressures from new entrants.
Sandila plant utilization at ~37-38%, expected to rise to 50-60% next year, lowering cost per litre and freight expenses.
Margin guidance stable around 15-17%, with no expectation of falling below 15% despite competitive pressures.

Vishnu Chemicals Limited VISHNU Q1FY27 📝 Transcript

Filed 05 Aug 2026

Capex of INR200-250 Cr planned for FY27, mainly for DMSO, chrome oxide green expansion, barium backward integration
Logistics cost rose to 9-10% in Q1, expected to rise to 20% in Q2; company working to pass on costs
Barium segment EBITDA margin impacted by one-off INR8 Cr expense; sustainable margin expected at 25%
South Africa mining operations expected to start in H2 FY27, aiding margin improvement
Long-term supply agreement for Chrome Oxide Green signed, providing volume and margin visibility
Q1 FY27 consolidated revenue grew 24.9% y-y to INR433.4 Cr; PAT up 23% to INR39.6 Cr

APL Apollo Tubes Limited APLAPOLLO Q1FY27 📝 Transcript · Capital Goods

Filed 05 Aug 2026

Employee cost increase due to annual increments and low production; expected to normalize with volume recovery.
July volumes rose 20% MoM; full-year EBITDA growth guidance maintained at 20% with 15-20% volume growth.
EBITDA per ton expected to improve gradually to INR6,000 over 2-3 years with capacity ramp-up.
Q1 FY27 volume was 745,000 tons, below expectations due to UAE geopolitical issues, energy crisis, and high inflation.
Solar segment expected to contribute 4-5% of volume in 2-3 years.
EBITDA per ton stable at INR5,500 despite 20% volume decline QoQ; gross profit per ton increased by INR1,000 QoQ.

BAJAJ FINSERV LTD. BAJAJFINSV Q1FY27 📝 Transcript · Finance

Filed 05 Aug 2026

Motor insurance pricing soft; tactical risk selection ongoing; combined ratio better than market by 16-18%
Consolidated total income grew 19% to INR 42,037 Cr; PAT up 18% to INR 6,297 Cr in Q1 FY27
Emerging businesses: Bajaj Finserv Direct breakeven expected Q3/Q4 FY27; Health breakeven FY28; Asset Mgmt AUM +26%
Insurance companies to adopt Ind AS from April 2027; potential impact from acquisition cost amortization and onerous contracts
Bajaj General: GWP +11.3%, underwriting loss INR 130 Cr, combined ratio 104.7%, profit INR 478 Cr, ROE 17.3%
Bajaj Life: retail premium +17.5%, VNB +87% to INR 271 Cr, NBM 15.9%, GWP +35%, PAT INR 51 Cr

KPIT Technologies Limited KPITTECH Q1FY27 📝 Transcript · Information Technology

Filed 04 Aug 2026

Q1 FY27 revenue nearly flat y-y with 0.1% constant currency growth, USD revenue down 0.6%, Q-o-Q decline 3.6%
H2 FY27 expected to see growth recovery, with Q4 driving return to growth and profitability
Medium-term margin aspiration of 22-24% by FY29 remains, driven by product/solution revenue growth and outcome-based models
European OEMs under pressure from China competition; KPIT engaged in cost reduction and speed-to-market initiatives to help clients
Pipeline strong globally; Europe impact expected to reflect more in Q2; US and SIMA regions showing growth
Strategic client revenue stable; decline mainly from top 2 clients and non-strategic segments

Aequs Limited AEQUS Q1FY27 📝 Transcript · Capital Goods

Filed 04 Aug 2026

Consumer segment EBITDA loss narrowed by INR112 million sequentially; on track for Q4 FY27 breakeven
Consumer utilization at 22%, expected to reach 40-50% by Q4 FY27
ROCE target steady at 18-22% for both segments; PAT breakeven expected by H1 FY28 for consumer
Capex guidance: INR660 Cr in FY27; Hosur integrated facility INR1,900 Cr over 10 years
Aerospace segment EBITDA margin at 23% with 40% revenue growth in Q1 FY27
Management confident on execution and growth trajectory for FY27

C.E. Info Systems Limited MAPMYINDIA Q1FY27 📞 Audio · Information Technology

Filed 04 Aug 2026

Strong open order book of Rs. 1750 Cr (+17% YoY) provides healthy revenue visibility for FY27.
Targeting 35%+ EBITDA margin for full year FY27.
Q1 FY27 revenue grew 14.9% YoY to Rs. 139.7 Cr; automotive segment up 29% YoY to Rs. 58.8 Cr.
IoT hardware sales growth (Rs. 23 Cr vs Rs. 7 Cr YoY) lowered blended margins; SaaS revenue expected to build over time.
IoT business margin pressure due to hardware-heavy early-stage revenue mix; SaaS ramp-up critical.
Q1 is seasonally weak for government segment; order execution ongoing with strong pipeline.

🎙 Transcript Summaries